Time to Invest in the Future: Assessing the Cost-Effectiveness of Empagliflozin in Diabetic Kidney Disease. Khine A, Kwok J, Lin E. Am J Kidney Dis 2022 Jan 31. pii: S0272-6386(21)01012.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khine A, Kwok J, Lin E. Time to Invest in the Future: Assessing the Cost-Effectiveness of Empagliflozin in Diabetic Kidney Disease. Am J Kidney Dis 2022 Jan 31. pii: S0272-6386(21)01012.
PMID: 35115191